Medgenics Reports First Quarter 2015 Financial Results - Nasdaq PDF Print
Nasdaq
Moving forward, we will focus on initiating small proof-of-concept studies in additional renal indications through the remainder of 2015, beginning with the study of end-stage renal disease (ESRD) patients undergoing peritoneal dialysis now underway in

...

 
Share |
Copyright © 2024 Global Dialysis. All Rights Reserved.